International Drugmakers Earn Warning Letters Over Quality Controls

International Pharmaceutical Regulatory Monitor
A A
The FDA issued warning letters to two international drug manufacturers for breaching GMP standards by failing to develop procedures to maintain the appropriate quality controls.

To View This Article:

Login

Subscribe To International Pharmaceutical Regulatory Monitor